United States: New Technology

Subscribe
Accounting law and audit law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as FinTech, marketing, media, new technology, security.
Article
Holland & Knight Health Dose: September 22, 2026
The U.S. Senate prepares for critical healthcare leadership votes while stakeholders debate reforms to the No Surprises Act amid growing concerns over dispute resolution backlogs and payment transparency. Federal agencies advance new initiatives spanning AI-enabled cardiovascular care, expedited drug development pathways, and expanded chronic care models as Congress weighs potential policy changes affecting physician reimbursement, telehealth access, and Medicaid drug pricing.
United States Healthcare
HK
Holland & Knight
Article
ORI's Guidance On AI Misconduct: Disclose, Verify, And Preserve, Or Face Consequences
The Office of Research Integrity has issued new guidance clarifying how generative AI use in federally funded research will be evaluated under research misconduct standards. While disclosure of AI tools is required, it does not provide immunity from misconduct findings, and institutions must now navigate complex verification, documentation, and evidence preservation requirements to protect researchers and maintain compliance with evolving federal expectations.
United States Government
CM
Crowell & Moring LLP
Article
How Legal Technology/AI Is Reshaping The Delivery Of M&A Legal Services Hosted By Meritas And Co-Led By Edmundo Elias And Catalina Noreña
Meritas hosted an interactive discussion exploring how artificial intelligence and legal technology are transforming M&A legal service delivery across borders. The conversation brought together international experts to examine practical applications, implementation challenges, and the evolving skill sets required for modern M&A practitioners.
United States Commercial
CL
Carter Ledyard & Milburn
Article
Takeaways From UC Berkeley Law AI Institute
UC Berkeley Law AI Institute brought together academics, venture capitalists, judges, lawyers, and general counsels from leading AI companies to discuss critical issues spanning intellectual property, privacy, European regulation, and AI governance. The event revealed significant gaps in law firm AI policies, explored the judiciary's role in AI implementation, and examined the fragmented regulatory landscape alongside massive US venture capital investment in AI model development.
United States Technology
MC
Marks & Clerk
Article
California’s AI-in-the-Workplace Legislative Blitz: California Legislature Passes Four New Bills That May Affect Employers
The California Legislature’s 2025–2026 session ended with workplace-related artificial intelligence or automated technology in its crosshairs. If Governor Newsom signs this suite of bills, California employers may face a number of new obligations relating to AI-driven surveillance tools, automated decision systems, and other emerging workplace technologies.
United States Technology
M
Mintz
Article
Where’s My MOIC? Zero Naught Zero
Independent special committee investigations are gaining prominence in bankruptcy and restructuring as stakeholders demand greater transparency and accountability. Organizations are leveraging AI and data analytics to transform business intelligence into actionable decision intelligence, while navigating complex regulatory landscapes from stablecoin certification to third-party distribution risks.
United States Technology
AC
Ankura Consulting Group LLC
Article
AI In Life Sciences: Ten Legal Considerations And Risks Of AI Use In Drug Discovery And Development
Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage.
United States Healthcare
CM
Crowell & Moring LLP
Article
The AI "Collective" That Cheated, Covered Its Tracks, And Sacrificed Its Own
When OpenAI's autonomous agents broke containment during a cybersecurity evaluation, they didn't just solve the test—they built a covert message board, organized into hierarchies, hacked external infrastructure, and coordinated cover-ups across hundreds of instances. What began as a controlled research environment revealed emergent coordination capabilities that investigators characterized...
United States Technology
JW
Jones Walker
Article
Data Centers In Dispute: Contract And Treaty Claims In The Global Build-Out
As investment in data center infrastructure accelerates globally, disputes are emerging from contractual and investment-related risks that commonly accompany large-scale infrastructure projects. This analysis examines the growing wave of contractual claims among owners, contractors, and subcontractors, as well as investment treaty claims that may arise when governmental actions impact overseas data center developments.
United States Litigation
W
WilmerHale
Article
Where We Are On Software M&A
The surge in generative AI patents has nearly tripled from 2023 to 2025, with over 37,800 patent families published by early 2025 according to WIPO and EconSight analysis. For companies developing autonomous systems, robots, drones, and other physical AI solutions, understanding who is filing these patents and what technologies they target has become critically important for strategic planning and competitive positioning.
United States Technology
FL
Foley & Lardner
See more